Alexandria Real Estate Equities

Alexandria Real Estate Equities is a private equity firm focused on real estate investments involved in the cluster formation of science based companies primarily operating in the life science industry that is headquartered in Pasadena, California and was founded in 1994 by Joel Marcus.

Alexandria Venture Investments operates as a private equity firm. The Company focuses on commercial and residential properties. Alexandria Venture Investments serves clients in the United States.

Founded in 1996, Alexandria Venture Investments is a corporate venture arm of Alexandria Real Estate Equities.

The firm invests in seed and early-stage businesses operating in the life science, healthcare, food, agriculture, and biotechnology sectors.

Alexandria Venture Investments, the strategic investment arm of Alexandria Center® at Kendall Square, is involved in innovation and entrepreneurship by investing capital in diverse science and technology sectors.The firm provides strategic investment capital to innovative life science and technology entities developing breakthrough therapies and technologies.

Alongside commercial and residential properties, Alexandria also focuses on biotechnology investments.

Alexandria Venture Investments has made over 50 investments. A large investment was made on Jan 30, 2019, when they invested $60M in Dewpoint Therapeutics.

Alexandria Venture Investments has had 10 exits. Alexandria Venture Investments's most notable exits include TCR2, Moderna Therapeutics, and Gritstone Oncology.